Copper-Catalyzed Intermolecular Trifluoromethylazidation of Alkenes: Convenient Access to CF<sub>3</sub>-Containing Alkyl Azides
作者:Fei Wang、Xiaoxu Qi、Zhaoli Liang、Pinhong Chen、Guosheng Liu
DOI:10.1002/anie.201309991
日期:2014.2.10
A novel copper‐catalyzed intermoleculartrifluoromethylazidation of alkenes has been developed under mild reaction conditions. A variety of CF3‐containing organoazides were directly synthesized from a wide range of olefins, including activated and unactivated alkenes, and the resulting products can be easily transformed into the corresponding CF3‐containing amine derivatives.
SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF
申请人:Brüggemeier Ulf
公开号:US20100261771A1
公开(公告)日:2010-10-14
The present application relates to new, substituted 2-acetamido-5-aryl-1,2,4-triazolones, to processes for preparing them, to their use alone or in combinations for the treatment and/or prevention of diseases and also to their use for the production of medicaments for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of cardiovascular disorders.
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
申请人:Xenon Pharmaceuticals Inc.
公开号:US20180162868A1
公开(公告)日:2018-06-14
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
[EN] BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS<br/>[FR] COMPOSÉS BENZOLACTAMES UTILISÉS EN TANT QU'INHIBITEURS DE PROTÉINE KINASE
申请人:OTSUKA PHARMA CO LTD
公开号:WO2017068412A1
公开(公告)日:2017-04-27
The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof. The compounds are inhibitors of ERK 1/2 kinases and will be useful in the treatment of ERKl/2-mediated conditions. The compounds are therefore useful in therapy, in particular in the treatment of cancer.
Copper-Catalyzed Three-Component Azidotrifluoromethylation/Difunctionalization of Alkenes
作者:Mingbo Yang、Wenlu Wang、Yin Liu、Lijie Feng、Xuexia Ju
DOI:10.1002/cjoc.201400167
日期:2014.9
A novel three‐component strategy for the azidotrifluoromethylation of alkenes has been presented here. The reaction proceeded smoothly under gentle temperature and gave the bifunctional olefins in high yields. Furthermore, 1,3‐dipolar reactions between azide‐containing products and phenylacetylene revealed great potential in molecular modification by using this method.